Skip to content
  • Saturday, 12 September 2026
  • 6:28 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cornell University Scientists Identify New Pathway for Reversible Nonhormonal Male Contraceptive Targeting Meiosis
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify New Pathway for Reversible Nonhormonal Male Contraceptive Targeting Meiosis

Dwi Wanna Jun 5, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception Through Meiotic Inhibition

Dwi Wanna May 29, 2026 0

The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Develop Breakthrough Reversible Nonhormonal Male Contraceptive Through Targeted Meiotic Disruption

Dwi Wanna May 22, 2026 0

In a significant advancement for reproductive medicine, a team of researchers at Cornell University has announced a major breakthrough in…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Achieve Milestone in Developing Reversible Nonhormonal Male Contraceptive Targeting Meiosis

Dwi Wanna May 14, 2026 0

The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Potential Pathway for Reversible Non-Hormonal Male Contraceptive Targeting Meiosis

Dwi Wanna May 7, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for a safe, reversible,…

Read More
Stem Cell & Regenerative Medicine

Cornell University scientists develop a safe reversible and long-acting nonhormonal male contraceptive through targeted meiotic disruption

Dwi Wanna Apr 30, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for nonhormonal male contraception…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Develop Safe and Reversible Nonhormonal Male Contraceptive Targeting the Meiosis Process

Dwi Wanna Apr 23, 2026 0

In a milestone for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for a…

Read More
Neuroscience & Brain Research

Cornell Researchers Develop Grain-of-Salt Sized Neural Implant for Long-Term Wireless Brain Monitoring

Rifan Muazin Apr 21, 2026 0

In a landmark achievement for the fields of bioengineering and microelectronics, a multidisciplinary team at Cornell University has announced the…

Read More
Stem Cell & Regenerative Medicine

Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic Interruption

Dwi Wanna Apr 15, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant advancement in the quest for…

Read More
Neuroscience & Brain Research

Cornell University Researchers Develop Grain of Salt Sized Neural Implant for Long Term Wireless Brain Monitoring

Rifan Muazin Apr 13, 2026 0

In a landmark achievement for the field of neurotechnology, a multidisciplinary team of researchers at Cornell University has engineered a…

Read More

Posts pagination

1 2 3
Lilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025The Hidden Skill Gap: Why SQL and Python Are No Longer Enough for Data ProfessionalsThe 988 Suicide and Crisis Lifeline is Associated with a Decline in Suicide Mortality Among U.S. YouthTWiV 1293: The enemy of your parasite is your friend
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy PorustobartScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ